Speaker

Karen McGuire

Chief Executive Officer, BioMendix

Karen McGuire, Chief Executive Officer at BioMendix, is speaking at 10th Dermatology Drug Development Summit (Boston, United States of America, 3–5 Nov 2026) in the session “Workshop B: Rare & Ultra-Rare Inflammatory Skin Disease: Exploring Under-Researched Populations to Address High Unmet Need & Unlock Scalable Innovation”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

10th Dermatology Drug Development Summit
3–5 Nov 2026Boston, United States of America
- WorkshopWorkshop B: Rare & Ultra-Rare Inflammatory Skin Disease: Exploring Under-Researched Populations to Address High Unmet Need & Unlock Scalable Innovation
- SpeakerLeveraging mTOR Inhibition to Restore Keratinocyte Homeostasis Across Rare Monogenic Skin Disorders

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Karen McGuire, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].